Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
BP medication recalled | FDA approves HF therapy | AI & cardiac imaging | A historic TAVR | More from the last week
Saturday, October 29, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA announces new recall of blood pressure medication due to potential cancer risk

Patients impacted by this recall are advised to speak with a physician about how to proceed. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces new recall of blood pressure medication due to potential cancer risk

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
Patients impacted by this recall are advised to speak with a physician about how to proceed. 
READ MORE >

Regulatory Roundup: FDA approves new heart failure therapy, clears an interventional device and much more

The FDA has been busy this month. Review some of the biggest FDA-related stories of October, including big news from scPharmaceuticals, Abiomed, Bristol Myers Squibb and MedAlliance, in our monthly roundup. 

READ MORE >
approved approval
Share on Twitter Share on Facebook Share on Linkedin

Regulatory Roundup: FDA approves new heart failure therapy, clears an interventional device and much more

Share on Twitter Share on Facebook Share on Linkedin
approved approval
The FDA has been busy this month. Review some of the biggest FDA-related stories of October, including big news from scPharmaceuticals, Abiomed, Bristol Myers Squibb and MedAlliance, in our monthly roundup. 
READ MORE >

VIDEO: The role of AI in cardiac imaging

Ed Nicol, MD, president-elect of the Society of Cardiovascular Computed Tomography, provided us with an exclusive look at how AI is expected to change cardiac imaging.

READ MORE >
AI-generated coronary tree from a patient's CT scan showing a color code of areas of interest for plaque burden from the Cleerly software shown at SCCT 2022.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: The role of AI in cardiac imaging

Share on Twitter Share on Facebook Share on Linkedin
AI-generated coronary tree from a patient's CT scan showing a color code of areas of interest for plaque burden from the Cleerly software shown at SCCT 2022.
Ed Nicol, MD, president-elect of the Society of Cardiovascular Computed Tomography, provided us with an exclusive look at how AI is expected to change cardiac imaging.
READ MORE >

Cardiologists make history, perform first UNICORN procedure during valve-in-valve TAVR

BASILICA was considered for the 67-year-old female patient, but UNICORN was seen as an overall better option. The full case study was published in Circulation: Cardiovascular Interventions.

READ MORE >
A team of cardiologists and cardiac surgeons in Hong Kong has performed the first successful undermining iatrogenic coronary obstruction with radiofrequency needle procedure—or UNICORN for short—on a high-risk valve-in-valve transcatheter aortic valve replacement (TAVR) patient. The group wrote about their experience in Circulation: Cardiovascular Interventions, a journal launched and distributed by the American Heart Association.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists make history, perform first UNICORN procedure during valve-in-valve TAVR

Share on Twitter Share on Facebook Share on Linkedin
A team of cardiologists and cardiac surgeons in Hong Kong has performed the first successful undermining iatrogenic coronary obstruction with radiofrequency needle procedure—or UNICORN for short—on a high-risk valve-in-valve transcatheter aortic valve replacement (TAVR) patient. The group wrote about their experience in Circulation: Cardiovascular Interventions, a journal launched and distributed by the American Heart Association.
BASILICA was considered for the 67-year-old female patient, but UNICORN was seen as an overall better option. The full case study was published in Circulation: Cardiovascular Interventions.
READ MORE >

Researchers awarded $31M to study conduction system pacing among heart failure patients

“Once the study begins, it will likely be one of the largest heart pacing clinical trials happening in the world over the next few years," one specialist said. 

READ MORE >
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Researchers awarded $31M to study conduction system pacing among heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
“Once the study begins, it will likely be one of the largest heart pacing clinical trials happening in the world over the next few years," one specialist said. 
READ MORE >

Heart damage after COVID-19 vaccination extremely rare among adolescents

Vaccine-related myocarditis was seen in approximately 0.00005% of children between the ages of 12 and 15. All cases were mild, and the median length of stay at the hospital was three days. 

READ MORE >
Vaccine-related myocarditis was seen in approximately 0.00005% of children between the ages of 12 and 15. All cases were mild, and the median length of stay at the hospital was three days. . Vaccine child kid young patient covid-19 mask patient
Share on Twitter Share on Facebook Share on Linkedin

Heart damage after COVID-19 vaccination extremely rare among adolescents

Share on Twitter Share on Facebook Share on Linkedin
Vaccine-related myocarditis was seen in approximately 0.00005% of children between the ages of 12 and 15. All cases were mild, and the median length of stay at the hospital was three days. . Vaccine child kid young patient covid-19 mask patient
Vaccine-related myocarditis was seen in approximately 0.00005% of children between the ages of 12 and 15. All cases were mild, and the median length of stay at the hospital was three days. 
READ MORE >

E-cigarettes linked to AFib, other heart rhythm issues in ‘highly concerning’ new study

“The findings of this study are important because they provide fresh evidence that the use of e-cigarettes could interfere with normal heart rhythms—something we did not know before,” according to one specialist. 

READ MORE >
E-cig. Using e-cigarettes may be associated with a heightened risk of atrial fibrillation (AFib) or other heart rhythm issues, according to new research published in Nature Communications.
Share on Twitter Share on Facebook Share on Linkedin

E-cigarettes linked to AFib, other heart rhythm issues in ‘highly concerning’ new study

Share on Twitter Share on Facebook Share on Linkedin
E-cig. Using e-cigarettes may be associated with a heightened risk of atrial fibrillation (AFib) or other heart rhythm issues, according to new research published in Nature Communications.
“The findings of this study are important because they provide fresh evidence that the use of e-cigarettes could interfere with normal heart rhythms—something we did not know before,” according to one specialist. 
READ MORE >

TEER reduces mitral regurgitation, boosts survival among cardiogenic shock patients

Researchers tracked outcomes data and imaging results from nearly 4,000 TEER patients, sharing their findings in the Journal of the American College of Cardiology.

READ MORE >
elderly patient mask covid
Share on Twitter Share on Facebook Share on Linkedin

TEER reduces mitral regurgitation, boosts survival among cardiogenic shock patients

Share on Twitter Share on Facebook Share on Linkedin
elderly patient mask covid
Researchers tracked outcomes data and imaging results from nearly 4,000 TEER patients, sharing their findings in the Journal of the American College of Cardiology.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme